糖尿病视网膜病变

  • 【医】diabetic retinopathy
糖尿病视网膜病变糖尿病视网膜病变
  1. 糖尿病视网膜病变与核因子-κB活性的关系

    Relationship between activity of nuclear factor - κ B and diabetic retinopathy

  2. 糖尿病视网膜病变血浆与房水中血小板源性生长因子B含量的相关研究

    Level of platelet-derived growth factor-B in plasma and aqueous humor in diabetic retinopathy

  3. D-α-生育酚调节蛋白激酶C活性对糖尿病视网膜病变的影响

    Effect of D - α - tocopherol on diabetic retinopathy via regulating protein kinase C activity

  4. 醛糖还原酶基因启动区C(-106)T多态性与糖尿病视网膜病变相关性研究

    Relationship between C ( - 106 ) T Polymorphism of Aldose Reductase Promoter Region and Diabetic Retinopathy

  5. 血浆VEGF水平与糖尿病视网膜病变的关系

    The Relationship between Plasma VEGF Levels and Diabetic Retinopathy

  6. 糖尿病视网膜病变血清IgG型抗内皮细胞抗体检测

    Detection of Serum IgG Anti-Endothelial Cell Antibodies in Diabetic Retinopathy

  7. 目的总结倍频YAG激光光凝治疗糖尿病视网膜病变临床疗效。

    Aim To study the clinical effect of double-frequency laser photocoagulation on diabetic retinopathy .

  8. 糖尿病视网膜病变(DR)是20~74岁人群的主要致盲原因。

    Diabetic retinopathy remains a leading cause of blindness between 20 and 74 years old .

  9. 血清Leptin和TNF-α与2型糖尿病视网膜病变的相关关系研究

    Correlation of serum Leptin and TNF - α to type 2 diabetic retinopathy

  10. 目的寻求糖尿病视网膜病变(DR)的有效治疗药物。

    [ Objective ] To find an effective medicine in treating diabetic retinopathy ( DR ) .

  11. 糖尿病视网膜病变患者VEGF和IFN-γ及NO检测的临床价值

    Clinical values of detection of VEGF , IFN - γ and NO in patients with diabetic retinopathy

  12. 糖尿病视网膜病变前期NOS亚型的蛋白表达及其在血流变化中作用的实验研究

    Relationship Between Expression of NOS Subtypes and Retinal Blood Flow in Diabetic Rat Retina

  13. 目的研究2型糖尿病视网膜病变(Diabeticretinopathy,DR)患者特异的血清低分子量蛋白质指纹图谱。

    Purpose To establish a type 2 diabetic retinopathy ( DR ) specific serum protein fingerprint profile .

  14. 推测EPC在糖尿病视网膜病变发病机制中起着非常重要的作用。

    EPCs maybe plays an important role in the pathogenesis of diabetic retinopathy .

  15. 糖尿病视网膜病变(DR)是引起视功能严重损害的主要视网膜血管疾病。

    Diabetic retinopathy ( DR ) is the main retina vascular disease which causes severe destruction to visual function .

  16. 目的探讨红细胞膜脂肪酸成分和膜流动性与糖尿病视网膜病变(DR)之间的关系。

    Objective To investigate the relationship between erythrocyte membrane fluidity and fatty acid components and diabetic retinopathy ( DR ) .

  17. 目的探讨大鼠糖尿病视网膜病变(DR)早期视网膜毛细血管及视细胞(视感受器)的病变规律。

    Objective To explore the law of pathologic changes in retinal capillaries and visual cells ( visual receptors ) in rats with diabetes .

  18. 视网膜新生血管形成和黄斑水肿是糖尿病视网膜病变(Diabeticretinopathy,DR)的主要临床表现,也是DR主要的致盲原因。

    Retinal neovascularization and macular edema are the main clinical signs of diabetic retinopathy ( DR ), and also the causes of blindness .

  19. 目的探讨达纳康对糖尿病视网膜病变(Diabeticretinopathy,DR)视网膜光凝术后眼前段改变的干预效果。

    Purpose To investigate the effects of intervention with Tanakan on anterior ocular segment in diabetic retinopathy ( DR ) after retinal photocoagulation .

  20. 目的探讨婚姻支持对糖尿病视网膜病变(DR)患者心理和生活质量的影响。

    Objective To study the effect of marital supports on quality of life and psychological status in patients with diabetic retinopathy ( DR ) .

  21. 中国汉族人血管紧张素转换酶基因多态性与糖尿病视网膜病变相关性Meta分析

    Meta-analysis of the association between the insertion / deletion polymorphism of the angiotensin converting enzyme gene and diabetic retinopathy

  22. 结论白细胞粘附发生在糖尿病视网膜病变(Diabeticretinopathy,DR)的早期阶段,是DR在微血管水平病理变化的开端。

    Conclusion Leukocyte adhesion occurs in the early stage of diabetic retinopathy ( DR ), and is the beginning of the microvascular pathological changes .

  23. 背景和目的糖尿病视网膜病变(Diabeticretinopathy,DR)是糖尿病的严重并发症,是成年人致盲的主要原因之一。

    Background and Aim Diabetic Retinopathy ( DR ) is a serious complication of diabetes and a leading cause of legal blindness in working-age adults .

  24. 目的:探讨早期糖尿病视网膜病变荧光血管造影所见及其与中医证型的关系,为临床进一步深入了解DR的早期发生规律及治疗提供客观依据。

    Part II Clinic ResearchAims : To investigate the relationship between the various shows of diabetes retina fluorescence angiographys in early stage and differentiation in TCM .

  25. 目的从临床角度对比早期糖尿病视网膜病变(DR)和糖尿病肾病(DN)两者间的关系。

    Objective To study the relationship between early diabetic retinopathy ( DR ) and diabetic nephropathy ( DN ) in a clinical context .

  26. 结果在亚临床期糖尿病视网膜病变时,OPs总波幅及各子波波幅和P-ERG的b波波幅均降低,与正常对照组比较,差异均有显著性;

    Results The differences were significant in the amplitude of OPs and b-wave of P-ERG between two groups ;

  27. 研究背景近年来越来越多的证据显示,糖尿病视网膜病变(Diabeticretinopathy,DRP)早期是一种低度慢性炎症。

    Background More and more evidence show that diabetic retinopathy ( DRP ) is an inflammatory disease at chronic low grade .

  28. 结论OPs总波幅及各子波波幅和P-ERG的b波波幅在亚临床期糖尿病视网膜病变时即有改变,波幅的改变比潜伏期改变敏感;

    Conclusion The amplitude of OPs and b-wave of P-ERG has changed in patient with sub-clinical stage of DR ;

  29. Bevacizumab与曲安奈德联合应用治疗严重增殖性糖尿病视网膜病变

    Bevacizumab Combined with Triamcinolone for the Treatment of Severe Proliferative Diabetic Retinopathy

  30. 方法采用VERISIV视觉诱发反应图像系统测量和分析增生型糖尿病视网膜病变(III~IV期)患者30例(30只眼)多焦视网膜电图改变。

    METHODS Thirty patients ( 30 eyes ) with proliferative diabetic retinopathy ( III ~ IV stages ) were tested with VERIS IV visual evoked response imaging system .